Condition

Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (2)

Overall Status

Recruiting (2)

Sign in for free

Phase

phase 1 (1)

phase 3 (1)

Sponsor

AstraZeneca (1)

University of California, San Diego (1)

Collaborator

Intervention

acalabrutinib (1)

hdmp + rituximab as a means of debulking prior to initiating venetoclax. (1)

obinutuzumab (1)

venetoclax (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (1)

Other (1)

Study Type

Interventional (2)

chronic lymphocytic leukemia or small lymphocytic lymphoma

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Trial in Worldwide (Acalabrutinib, Venetoclax, Obinutuzumab)

Recruiting

Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Acalabrutinib
+2 more

Tucson, Arizona
+40 more

Dec 20, 2022

Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Trial in La Jolla (HDMP + rituximab as a means of debulking prior to

Recruiting

Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

HDMP + rituximab as a means of debulking prior to initiating venetoclax.

La Jolla, California

UCSD Moores Cancer Center

Mar 21, 2022